- Kazuistika s dlouhodobou léčebnou odpovědí na terapii axitinibem2019 | First Faculty of Medicine
- Dlouhodobá léčebná odpověď na trifluridin/tipiracil ve třetí linii léčby metastatického kolorektálního karcinomu2021 | Third Faculty of Medicine
- Dlouhodobá léčebná odpověď na crizotinib u pacientky s adenokarcinomem plic2017 | First Faculty of Medicine
- Maintenance treatment in non-Hodgkin´s lymphoma +12009 | Publication without faculty affiliation
- Long-term response to sequential treatment with tyrosine kinase inhibitors in a patient with EGFR+ adenocarcinoma2021 | Third Faculty of Medicine
- Complete remission and long-term response to gemcitabine + nab-paclitaxel in patient with metastatic pancreatic adenocarcinoma2021 | Third Faculty of Medicine
- Dlouhodobá odpověď na lenvatinib u pacienta s hepatocelulárním karcinomem - kazuistika2021 | Third Faculty of Medicine
- Další průběžné výsledky studie COMBI-i2020 | Third Faculty of Medicine
- Pembrolizumab as a first-line therapy in spinocellular esophageal cancer2021 | First Faculty of Medicine
- Dabrafenib in the treatment of metastatic melanoma2015 | Publication without faculty affiliation